Prejunctional action of neostigmine on mouse neuromuscular preparations

M.F.M. Braga, E.G. Rowan, Alan L. Harvey, W.C. Bowman

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

We have studied the effects of neostigmine on the mouse diaphragm and triangularis sterni isolated nerve-muscle preparations. Mechanical responses of the muscle, end-plate potentials and miniature end-plate potentials, and extracellularly recorded nerve ending currents were recorded. In the mouse diaphragm nerve-muscle preparations, neostigmine 1 mumol litre-1 continued to produce some antagonism of tubocurarine-induced block after cholinesterase had been inactivated completely by diisopropyl fluorophosphate 22 mumol litre-1. In the mouse triangularis sterni preparation, neostigmine 0.1-1 mumol litre-1 increased the quantal content of the end-plate potential in a concentration-dependent manner. This effect appeared to be sufficient to account for the cholinesterase-independent antagonistic action to tubocurarine under the conditions of the experiments. Neostigmine 1-100 mumol litre-1 depressed the amplitude of the K+ currents of the perineural waveforms in a concentration-dependent manner, and this may account for its ability to increase the quantal content of the end-plate potential. Although inhibition of acetyl-cholinesterase is the main mechanism of action of neostigmine, the drug also exerts an additional direct action on motor nerve endings to block the delayed rectifier K+ channels and enhance transmitter release. This effect occurred at clinically relevant concentrations of neostigmine. Physostigmine and pyridostigmine did not possess this additional action.
LanguageEnglish
Pages405-410
Number of pages5
JournalBritish Journal of Anaesthesia
Volume70
Issue number4
DOIs
Publication statusPublished - Apr 1993

Fingerprint

Neostigmine
Excitatory Postsynaptic Potentials
Cholinesterases
Tubocurarine
Nerve Endings
Neuromuscular Junction
fluorophosphate
Diaphragm
Miniature Postsynaptic Potentials
Pyridostigmine Bromide
Physostigmine
Muscles
Pharmaceutical Preparations

Keywords

  • nicotinic acetylcholine receptor
  • motor nerve terminals
  • muscle
  • anticholinesterases
  • pyridostigmine

Cite this

@article{e230c2a980a64dad919ca35407ab5f9b,
title = "Prejunctional action of neostigmine on mouse neuromuscular preparations",
abstract = "We have studied the effects of neostigmine on the mouse diaphragm and triangularis sterni isolated nerve-muscle preparations. Mechanical responses of the muscle, end-plate potentials and miniature end-plate potentials, and extracellularly recorded nerve ending currents were recorded. In the mouse diaphragm nerve-muscle preparations, neostigmine 1 mumol litre-1 continued to produce some antagonism of tubocurarine-induced block after cholinesterase had been inactivated completely by diisopropyl fluorophosphate 22 mumol litre-1. In the mouse triangularis sterni preparation, neostigmine 0.1-1 mumol litre-1 increased the quantal content of the end-plate potential in a concentration-dependent manner. This effect appeared to be sufficient to account for the cholinesterase-independent antagonistic action to tubocurarine under the conditions of the experiments. Neostigmine 1-100 mumol litre-1 depressed the amplitude of the K+ currents of the perineural waveforms in a concentration-dependent manner, and this may account for its ability to increase the quantal content of the end-plate potential. Although inhibition of acetyl-cholinesterase is the main mechanism of action of neostigmine, the drug also exerts an additional direct action on motor nerve endings to block the delayed rectifier K+ channels and enhance transmitter release. This effect occurred at clinically relevant concentrations of neostigmine. Physostigmine and pyridostigmine did not possess this additional action.",
keywords = "nicotinic acetylcholine receptor, motor nerve terminals, muscle, anticholinesterases, pyridostigmine",
author = "M.F.M. Braga and E.G. Rowan and Harvey, {Alan L.} and W.C. Bowman",
year = "1993",
month = "4",
doi = "10.1093/bja/70.4.405",
language = "English",
volume = "70",
pages = "405--410",
journal = "British Journal of Anaesthesia",
issn = "0007-0912",
number = "4",

}

Prejunctional action of neostigmine on mouse neuromuscular preparations. / Braga, M.F.M.; Rowan, E.G.; Harvey, Alan L.; Bowman, W.C.

In: British Journal of Anaesthesia, Vol. 70, No. 4, 04.1993, p. 405-410.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Prejunctional action of neostigmine on mouse neuromuscular preparations

AU - Braga, M.F.M.

AU - Rowan, E.G.

AU - Harvey, Alan L.

AU - Bowman, W.C.

PY - 1993/4

Y1 - 1993/4

N2 - We have studied the effects of neostigmine on the mouse diaphragm and triangularis sterni isolated nerve-muscle preparations. Mechanical responses of the muscle, end-plate potentials and miniature end-plate potentials, and extracellularly recorded nerve ending currents were recorded. In the mouse diaphragm nerve-muscle preparations, neostigmine 1 mumol litre-1 continued to produce some antagonism of tubocurarine-induced block after cholinesterase had been inactivated completely by diisopropyl fluorophosphate 22 mumol litre-1. In the mouse triangularis sterni preparation, neostigmine 0.1-1 mumol litre-1 increased the quantal content of the end-plate potential in a concentration-dependent manner. This effect appeared to be sufficient to account for the cholinesterase-independent antagonistic action to tubocurarine under the conditions of the experiments. Neostigmine 1-100 mumol litre-1 depressed the amplitude of the K+ currents of the perineural waveforms in a concentration-dependent manner, and this may account for its ability to increase the quantal content of the end-plate potential. Although inhibition of acetyl-cholinesterase is the main mechanism of action of neostigmine, the drug also exerts an additional direct action on motor nerve endings to block the delayed rectifier K+ channels and enhance transmitter release. This effect occurred at clinically relevant concentrations of neostigmine. Physostigmine and pyridostigmine did not possess this additional action.

AB - We have studied the effects of neostigmine on the mouse diaphragm and triangularis sterni isolated nerve-muscle preparations. Mechanical responses of the muscle, end-plate potentials and miniature end-plate potentials, and extracellularly recorded nerve ending currents were recorded. In the mouse diaphragm nerve-muscle preparations, neostigmine 1 mumol litre-1 continued to produce some antagonism of tubocurarine-induced block after cholinesterase had been inactivated completely by diisopropyl fluorophosphate 22 mumol litre-1. In the mouse triangularis sterni preparation, neostigmine 0.1-1 mumol litre-1 increased the quantal content of the end-plate potential in a concentration-dependent manner. This effect appeared to be sufficient to account for the cholinesterase-independent antagonistic action to tubocurarine under the conditions of the experiments. Neostigmine 1-100 mumol litre-1 depressed the amplitude of the K+ currents of the perineural waveforms in a concentration-dependent manner, and this may account for its ability to increase the quantal content of the end-plate potential. Although inhibition of acetyl-cholinesterase is the main mechanism of action of neostigmine, the drug also exerts an additional direct action on motor nerve endings to block the delayed rectifier K+ channels and enhance transmitter release. This effect occurred at clinically relevant concentrations of neostigmine. Physostigmine and pyridostigmine did not possess this additional action.

KW - nicotinic acetylcholine receptor

KW - motor nerve terminals

KW - muscle

KW - anticholinesterases

KW - pyridostigmine

U2 - 10.1093/bja/70.4.405

DO - 10.1093/bja/70.4.405

M3 - Article

VL - 70

SP - 405

EP - 410

JO - British Journal of Anaesthesia

T2 - British Journal of Anaesthesia

JF - British Journal of Anaesthesia

SN - 0007-0912

IS - 4

ER -